5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Arrhythmias and Electrophysiology
Arrhythmias and electrophysiology focus on understanding the electrical activities of the heart and their role in maintaining a regular heartbeat. Advanced mapping techniques and ablation therapies have revolutionized the treatment of conditions like atrial fibrillation and ventricular tachycardia. Electrophysiology studies provide critical insights into identifying arrhythmic triggers and pathways, enabling precise interventions. Innovations such as leadless pacemakers and implantable cardioverter defibrillators (ICDs) have enhanced the management of life-threatening arrhythmias. Researchers are also delving into the genetic basis of arrhythmias, aiming to develop personalized therapeutic strategies. This domain continues to evolve, offering hope for improved quality of life and reduced mortality rates for patients with rhythm disorders.
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas J Webster
Brown University, United States
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Syed Raza
Awali Hospital, BahrainSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain